1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Mhealth (Mobile Health) Market Focus on Ecosystem (mHealth Devices & Services), Therapeutics, Application/ Solution Type & Regions – Estimation & Forecast through 2015 to 2022

The mHealth services dominated the market in 2014 and are expected to grow over $55.63 billion by the end of the forecast period due to the increasing usage of mHealth solutions by healthcare providers and pharmaceutical companies along with end users (patients). However, device segment is expected to grow in near future with a high CAGR of 38.02%, from 2015 to 2022, due to increasing integration of mHealth devices with smart phones and weareables, and also, increasing opportunities of connected health solutions are predicted to promote the growth of this market through the forecast period.

Report description

Mobile health (mHealth) is one of the most modernized trends in the healthcare industry that has shown tremendous progress in the last few years. This trend is observed due to the flourishing growth of personal health devices, which can be easily worn or used with a smartphone or tablet. Mobile Health refers to the use of mobile communications, such as personal digital assistant (PDAs), laptops, and mobile phones among others, for health services and information.

The study includes an analysis of therapeutics and applications in which mHealth is used, in addition to the market study of the mHealth devices and services used across different geographical regions. The study presents a detailed analysis of the mHealth ecosystem (devices and services), therapeutics, applications, and geography along these lines: market size, drivers, growth opportunities, and challenges. The major end-use application areas of mHealth devices and services with respect to the market size and growth rate has also been identified and discussed in the report.

Key question answered in the report:

- What are the major market drivers, challenges and opportunities of the mHealth market and their use cases?

- Which factors will be driving the market through the forecast period?

- What factors are currently challenging the mHealth industry?

- What are the use cases and key platforms to deliver the services of each application?

- What are the key developmental strategies in different applications across all regions?

- How will the key market players leverage on key developments such as Mergers and Acquisitions, Partnerships, and Product Launch among others?

- Which compliances and certifications are necessary to make a product acceptable?

- Which geographical region will lead the global mHealth market by the end of the forecast period?

- Who are the key players in the mHealth market?

Table Of Contents

Global Mhealth (Mobile Health) Market Focus on Ecosystem (mHealth Devices and Services), Therapeutics, Application/ Solution Type and Regions - Estimation and Forecast through 2015 to 2022
TABLE OF CONTENT
1 REPORT SCOPE
1.1 SCOPE OF THE STUDY
1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE
1.1.2 BIS RESEARCH METHODOLOGY
1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL MARKET STUDY
1.1.3.1 GEOGRAPHICAL ANALYSIS
1.1.3.2 DEMAND SIDE and SUPPLY SIDE ANALYSIS
1.1.3.3 DATA SYNTHESIS and BRIDGING
1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY
1.1.5 KEY DATA POINT SOURCES
1.1.5.1 DATA POINTS TAKEN FROM SECONDARY SOURCES
1.1.5.2 DATA POINTS TAKEN FROM PRIMARY SOURCES
1.1.6 REPORT DESCRIPTION
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 MARKET DRIVERS
3.2.1.1 PATIENTS INVOLVEMENT IN PERSONAL HEALTHCARE
3.2.1.2 PROLIFERATION OF SMARTPHONES AND WEARABLE DEVICES INTO HEALTHCARE
3.2.1.3 INTEGRATION OF WIRELESS TECHNOLOGIES WITH PORTABLE HEALTHCARE DEVICES
3.2.1.4 INTRODUCTION OF CONNECTED HEALTHCARE SOLUTIONS IN THE MHEALTH MARKET
3.2.1.5 BENEFITS OF COST EFFECTIVENESS AND PATIENTS' CONVENIENCE
3.2.1.6 INCREASE IN LIFESTYLE DISEASE
3.2.2 MARKET CHALLENGES
3.2.2.1 LOW RATE OF LITERACY AND LANGUAGE BARRIERS IN LOW- AND MIDDLE-INCOME COUNTRIES (LMICS)
3.2.2.2 INVASION OF PRIVACY
3.2.2.2.1 SECURITY BREACH CASES
3.2.2.2.2 POTENTIAL RISK OF HARDWARE OR SOFTWARE FAILURE
3.2.2.2.3 STRINGENT REGULATIONS AND STANDARDS
3.2.2.2.4 LACK OF AWARENESS ABOUT THE POSSIBLE APPLICATIONS OF MHEALTH
3.2.3 MARKET OPPORTUNITIES
3.2.3.1 PARTNERSHIP: AN ENTRY MODE
3.2.3.2 INTRODUCTION OF MHEALTH IN DEVELOPING ECONOMIES
4 INDUSTRY DYNAMICS
4.1 MHEALTH MARKET TIMELINE
4.2 VALUE CHAIN OF THE MHEALTH MARKET
4.2.1.1 DEVICE MANUFACTURERS
4.2.1.2 APP DEVELOPERS
4.2.1.3 NETWORK PROVIDERS/ MOBILE OPERATORS
4.2.1.4 HEALTHCARE PROVIDERS AND PHARMACEUTICALS
4.2.1.5 PATIENTS
4.2.1.6 CONSORTIUMS, CERTIFICATION, REGULATIONS, and STANDARDS
4.2.1.6.1 INTRODUCTION
4.2.1.6.2 CONSORTIUMS
4.2.1.6.3 ALLIANCE/ASSOCIATIONS
4.2.1.6.4 REGULATORY BODIES
4.2.1.7 FOOD AND DRUG ADMINISTRATION (FDA)
4.2.1.8 MEDICAL DEVICE REGULATION ACT
4.2.1.9 MEDICAL MOBILE APPLICATION(MMA)
4.2.2 CERTIFICATION
4.2.3 MHEALTH DEVICE: PORTER'S FIVE FORCE ANALYSIS
4.2.4 BARGAINING POWER OF BUYER
4.2.5 BARGAINING POWER OF SUPPLIER
4.2.6 THREAT FROM SUBSTITUTE
4.2.7 THREAT FROM A NEW ENTRANT
4.2.8 INTENSITY OF COMPETITIVE RIVALRY
5 GLOBAL MHEALTH MARKET ECOSYSTEM
5.1 INTRODUCTION
5.1.1 MHEALTH DEVICES
5.1.2 MEDICAL DEVICES
5.1.2.1 SMBG MONITOR
5.1.2.1.1 SMBG DEVICE TYPESand USES
5.1.2.1.2 DISEASES MANAGED BY SMBG DEVICE
5.1.2.1.3 KEY PLAYERS
5.1.2.2 BLOOD PRESSURE (BP) MONITOR
5.1.2.2.1 BP MONITOR DEVICE TYPES and USES
5.1.2.2.2 DISEASES MANAGED BY BP MONITOR DEVICE
5.1.2.2.3 KEY PLAYERS
5.1.2.2.4 PULSE OXIMETER
5.1.2.2.5 PULSE OXIMETER : TYPES and USES
5.1.2.2.6 DISEASES MANAGED BY PULSE OXIMETER DEVICE
5.1.2.2.7 KEY PLAYERS
5.1.2.3 CARDIAC MONITORS
5.1.2.3.1 DISEASES MANAGED BY CARDIAC MONITORS
5.1.2.3.2 DISEASE MANAGEMENT DEVICES TYPES
5.1.2.3.3 CARDIAC MONITOR USES
5.1.2.4 KEY PLAYERS
5.1.2.5 OTHER MEDICAL DEVICES
5.1.2.5.1 HEALTH AND FITNESS DEVICES
5.1.2.5.2 HAND WORN PRODUCTS
5.1.2.5.2.1 SMART WATCH
5.1.2.5.2.2 WRIST WEAR
5.1.2.5.3 KEY PLAYERS
5.1.2.5.4 HEAD WORN PRODUCTS
5.1.2.5.4.1 AR/VR HMD/HUD
5.1.2.5.4.2 OTHERS
5.1.2.5.4.3 BODY WORN PRODUCTS
5.1.2.5.4.4 SMART TEXTILE
5.1.2.5.4.5 WEARABLE PATCH
5.1.2.5.4.6 OTHERS
5.1.2.5.5 NON-CLINICAL APPLICATIONS
5.1.2.5.6 CLINICAL APPLICATION
5.1.2.6 OTHERS DEVICES
5.1.2.6.1 MOBILE TELEMEDICINE/TELE-CARE DEVICES
5.1.2.6.2 HOME CARE DEVICES
5.1.2.6.2.1 VESSYL
5.1.2.6.2.2 TAO
5.1.2.6.2.3 CUBESENSORS
5.1.2.6.2.4 KOLIBREE
5.1.2.6.2.5 TELLSPEC
5.1.2.6.2.6 KINSA
5.1.2.6.2.7 BEDDIT
5.1.2.6.2.8 WELLO IPHONE CASE
5.1.2.6.3 KEY PARTICIPANTS
5.1.2.7 MHEALTH SERVICES
5.1.3 MOBILE HEALTH APPS AND CONTENT SOLUTION
5.1.3.1 SOFTWARE
5.1.3.2 BIG DATA
5.1.3.3 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
5.1.3.3.1 MARKET TRENDS AND MARKET DEVELOPMENTS
5.1.3.3.2 KEY PARTICIPANTS
5.1.4 NETWORK AND SERVICES/ MOBILE OPERATORS
5.1.4.1 BENEFITS OF NETWORK and SERVICES
5.1.4.2 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
5.1.4.2.1 MARKET TRENDS AND MARKET DEVELOPMENTS
5.1.4.2.2 KEY PARTICIPANTS
5.1.5 HEALTHCARE AND PHARMACEUTICALS
5.1.5.1 HEALTHCARE PROVIDERS
5.1.5.2 PHARMACEUTICALS
5.1.5.2.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
5.1.5.2.1.1 MARKET TRENDS AND MARKET DEVELOPMENTS
5.1.5.2.1.2 KEY PARTICIPANTS
6 GLOBAL MHEALTHMARKET - THERAPEUTICS
6.1 INTRODUCTION
6.1.1 GLOBAL MARKET STATISTICS
6.1.1.1 CARDIOVASCULAR DISEASES
6.1.2 DEVICES
6.1.3 APPS
6.1.4 KEY PLAYERS
6.2 DIABETES
6.2.1 DEVICES
6.2.2 APPS
6.2.3 KEY PLAYERS
6.3 RESPIRATORY
6.3.1 DEVICES
6.3.2 APPS
6.3.3 KEY PLAYERS
6.4 MENTAL AND NEUROLOGICAL DISORDERS
6.4.1 DEVICES
6.4.2 APPS
6.4.3 KEY PLAYERS
6.5 FITNESS and LIFESTYLE THERAPEUTICS
6.5.1 DEVICES
6.5.2 APPS
6.5.3 KEY PLAYERS
6.6 OTHERS
7 GLOBAL MHEALTHMARKET - APPLICATION/ SOLUTION TYPE
7.1 INTRODUCTION
7.1.1 MONITORING APPLICATIONS
7.1.1.1 KEY PARTICIPANTS
7.1.2 DIAGNOSIS and TREATMENT
7.1.2.1 KEY PARTICIPANTS
7.1.3 EDUCATION AND AWARENESS
7.1.3.1 KEY PARTICIPANTS
7.1.4 HEALTHCARE MANAGEMENT
7.1.5 WELLNESS and PREVENTION
7.1.6 OTHERS/ OTHER SERVICES AND APPLICATIONS MARKET
7.1.7 REMOTE DATA COLLECTION
7.1.7.1 KEY MARKET DEVELOPMENTS
8 GLOBAL MHEALTH MARKET-GEOGRAPHY
8.1 INTRODUCTION
8.1.1 MARKET STATISTICS
8.1.2 THE AMERICAS
8.1.3 NORTH AMERICA
8.1.3.1 THE U.S.
8.1.3.1.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.3.1.1.1 KEY MARKET TRENDS AND DEVELOPMENTS
8.1.3.1.1.2 KEY PARTICIPANTS
8.1.3.2 CANADA
8.1.3.2.1 KEY MARKET TREND
8.1.3.2.2 KEY PLAYERS
8.1.3.3 SOUTH AMERICA
8.1.3.3.1 CONSTRAINTS
8.1.3.3.2 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.3.3.2.1 MARKET TRENDS AND MARKET DEVELOPMENTS
8.1.3.3.2.2 KEY PARTICIPANTS
8.1.4 ASIA-PACIFIC (APAC)
8.1.4.1 KEY DRIVERS IN APAC
8.1.4.1.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.4.1.1.1 MARKET TRENDS and DEVELOPMENT
8.1.4.1.1.2 KEY PARTICIPANTS
8.1.4.2 CHINA
8.1.4.3 JAPAN
8.1.4.4 AUSTRALIA
8.1.4.5 INDIA
8.1.5 EUROPE
8.1.5.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.5.2 THE U.K.
8.1.5.3 GERMANY
8.1.5.4 KEY PARTICIPANTS
8.1.6 REST OF THE WORLD (ROW)
8.1.6.1 AFRICA
8.1.6.1.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.6.1.1.1 MARKET TRENDS AND MARKET DEVELOPMENTS
8.1.6.1.2 KEY PARTICIPANTS
8.1.7 MIDDLE EAST
8.1.7.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.7.1.1 MARKET TRENDS AND MARKET DEVELOPMENTS
8.1.7.1.2 KEY PARTICIPANTS
9 KEY MARKET DEVELOPMENT AND STRATEGIES
9.1 INTRODUCTION
9.1.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
9.1.2 MERGERS and ACQUISITIONS
9.1.3 PRODUCT DEVELOPMENT AND LAUNCH
9.1.4 BUSINESS EXPANSION/CONTRACTS
9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS
9.1.6 OTHERS (EVENTS and RECOGNITIONS)
10 COMPANY PROFILES
1.1 AGAMATRIX, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 KEY DEVELOPMENTS
10.2 ALIVECOR, INC.
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 KEY DEVELOPMENTS
10.3 APPLE, INC.
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.2.1 OVERALL FINANCIALS
10.3.2.2 FINANCIALS BY SEGMENT
10.3.2.3 FINANCIALS BY REGION
10.3.2.4 FINANCIAL SUMMARY
10.3.3 KEY DEVELOPMENT
10.4 ATHENAHEALTH INC.
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.2.1 OVERALL FINANCIALS
10.4.2.2 FINANCIAL BY SEGMENTS
10.4.2.3 FINANCIAL SUMMARY
10.4.3 KEY DEVELOPMENT
10.5 ATandT, INC.
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.2.1 OVERALL FINANCIALS
10.5.2.2 FINANCIALS BY SEGMENT
10.5.2.3 FINANCIAL SUMMARY
10.5.3 KEY DEVELOPMENTS
10.6 BIOTELEMETRY, INC. (CARDIONET)
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.2.1 OVERALL FINANCIALS
10.6.2.2 FINANCIALS BY SEGMENT
10.6.2.3 FINANCIAL SUMMARY
10.6.3 KEY DEVELOPMENTS
10.7 GE HEALTHCARE
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.2.1 OVERALL FINANCIALS
10.7.2.2 FINANCIALS BY SEGMENT
10.7.2.3 FINANCIAL SUMMARY
10.7.3 KEY DEVELOPMENTS
10.8 GOOGLE INC.
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.2.1 FINANCIAL SUMMARY
10.8.3 KEY DEVELOPMENTS
10.9 JAWBONE, INC.
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 KEY DEVELOPMENTS
10.1 JOHNSON and JOHNSON
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.2.1 OVERALL FINANCIALS
10.10.2.2 NET REVENUE BY SEGMENT
10.10.2.3 NET REVENUE BY REGION
10.10.3 KEY DEVELOPMENTS
10.11 LABORATORY CORPORATION OF AMERICA HOLDINGS
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.2.1 OVERALL FINANCIALS
10.11.2.2 FINANCIALS BY SEGMENT
10.11.2.3 FINANCIAL SUMMARY
10.11.3 KEY DEVELOPMENTS
10.12 MEDTRONIC PLC
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.2.1 OVERALL FINANCIALS
10.12.2.2 FINANCIAL SUMMARY
10.12.3 KEY DEVELOPMENTS
10.13 NIKE INC.
10.13.1 OVERVIEW
10.13.2 FINANCIALS
10.13.2.1 OVERALL FINANCIALS
10.13.2.2 FINANCIALS BY SEGMENTS
10.13.2.3 FINANCIAL SUMMARY
10.13.3 KEY DEVELOPMENTS
10.14 PFIZER
10.14.1 OVERVIEW
10.14.2 FINANCIALS
10.14.2.1 OVERALL FINANCIALS
10.14.2.2 FINANCIALS BY SEGMENT
10.14.2.3 FINANCIALS BY REGION
10.14.2.4 FINANCIAL SUMMARY
10.14.3 KEY DEVELOPMENTS
10.15 PHILIPS HEALTHCARE
10.15.1 OVERVIEW
10.15.2 FINANCIALS
10.15.2.1 OVERALL FINANCIALS
10.15.2.2 FINANCIALS BY REGION
10.15.2.3 FINANCIALS BY SEGMENT
10.15.2.4 FINANCIAL SUMMARY
10.15.3 KEY DEVELOPMENTS
10.16 QUALCOMM, INC.
10.16.1 OVERVIEW
10.16.2 FINANCIALS
10.16.2.1 OVERALL FINANCIALS
10.16.2.2 FINANCIALS BY SEGMENT
10.16.2.3 FINANCIALS BY REGION
10.16.2.4 FINANCIAL SUMMARY
10.16.3 KEY DEVELOPMENTS
10.17 QUEST DIAGNOSTICS INC.
10.17.1 OVERVIEW
10.17.2 FINANCIALS
10.17.2.1 OVERALL FINANCIALS
10.17.2.2 FINANCIALS BY SEGMENT
10.17.2.3 FINANCIAL SUMMARY
10.17.3 KEY DEVELOPMENTS
10.18 ROCHE HOLDING AG-BR
10.18.1 OVERVIEW
10.18.2 FINANCIALS
10.18.2.1 OVERALL FINANCIALS
10.18.2.2 FINANCIALS BY SEGMENT
10.18.2.3 FINANCIAL SUMMARY
10.18.3 KEY DEVELOPMENTS
10.19 SAMSUNG ELECTRONICS CO. LTD.
10.19.1 OVERVIEW
10.19.2 FINANCIALS
10.19.2.1 OVERALL FINANCIALS
10.19.2.2 FINANCIAL SUMMARY
10.19.3 KEY DEVELOPMENTS
10.2 SANOFI PHARMA
10.20.1 OVERVIEW
10.20.2 FINANCIALS
10.20.2.1 OVERALL FINANCIALS
10.20.3 FINANCIALS BY SEGMENT
10.20.4 FINANCIAL SUMMARY
10.20.5 KEY DEVELOPMENTS
10.21 WITHINGS SAS
10.21.1 OVERVIEW
10.21.2 FINANCIALS
10.21.3 KEY DEVELOPMENTS
List of Tables
TABLE 1 LEADING COMPANIES IN THE MHEALTH MARKET
TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2011-2015)
TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS
TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM
TABLE 5 CONSORTIUMS IN MHEALTH MARKET
TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET
TABLE 7 REGULATORY BODIES IN MHEALTH MARKET
TABLE 8 MHEALTH MARKET CERTIFICATIONS
TABLE 9 FACTORS IMPACTING THE BUYER'S BARGAINING POWER
TABLE 10 FACTORS IMPACTING THE SUPPLIER'S BARGAINING POWER
TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE
TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT
TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION
TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2014-2022 ($MILLION)
TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)
TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2014-2022 ($MILLION)
TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)
TABLE 19 KEY DEVELOPMENTS
TABLE 20 NETWORK and SERVICES: KEY DEVELOPMENTS
TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT
TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25 TYPE OF APP
TABLE 26 KEY DEVELOPMENTS
TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 29 KEY DEVELOPMENTS
TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 34 FITNESS and LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 35 FITNESS and LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 40 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 41 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 42 REMOTE MONITORING IN GEOGRAPHIES
TABLE 43 DIAGNOSIS and TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 44 DIAGNOSIS and TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 45 DIAGNOSIS and TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES
TABLE 47 EDUCATION and AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 48 EDUCATION and AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 49 EDUCATION and AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 50 EDUCATION and WELLNESS IN GEOGRAPHIES
TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 52 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 53 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES
TABLE 55 WELLNESS and PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 56 WELLNESS and PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 57 WELLNESS and PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 58 WELLNESS and PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES
TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 62 MHEALTH: KEY DEVELOPMENTS (2011- 2015)
TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION)
TABLE 65 THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 66 THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 67 THE U.S.: KEY DEVELOPMENTS
TABLE 68 SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2011-2015)
TABLE 69 APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 70 APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 71 KEY DEVELOPMENTS IN APAC
TABLE 72 EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 73 EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 74 EUROPE: MHEALTH MARKET DEVELOPMENT
TABLE 75 ROW: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION)
TABLE 76 ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 77 ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 78 AFRICA: MHEALTH MARKET DEVELOPMENTS(2011-2014)
TABLE 79 MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2014-2011)
List of FIGURES
FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA
FIGURE 2 BIS RESEARCH METHODOLOGY
FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET
FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY
FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2014-2022 ($MILLION)
FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2014-2022 ($MILLION)
FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2022 ($MILLION)
FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
FIGURE 9 MARKET DRIVERS AND CHALLENGES
FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS
FIGURE 11 BENEFITS OF MHEALTH TO PATIENTS
FIGURE 12 EXAMPLES OF EXISTING MHEALTH INNOVATIONS
FIGURE 13 MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS
FIGURE 14 MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS
FIGURE 15 VALUE CHAIN
FIGURE 16 ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS
FIGURE 17 CLASSIFICATION OF MEDICAL DEVICES
FIGURE 18 MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS
FIGURE 19 MHEALTH ECOSYSTEM
FIGURE 20 TYPE OF MHEALTH DEVICES
FIGURE 21 SMBD DEVICE USES
FIGURE 22 USES OF BP MONITORING DEVICE
FIGURE 23 PULSE OXIMETER USES
FIGURE 24 WEARABLE DEVICE COMPONENTS
FIGURE 25 TYPE OF WEARABLE ELECTRONICS DEVICES
FIGURE 26 HAND WORN MHEALTH DEVICES
FIGURE 27 APPLE WATCH FIGURE
FIGURE 28 LEADING FITNESS TRACKING WRIST BANDS
FIGURE 29 GOOGLE'S CONTACT LENS
FIGURE 30 HEAD WORN DEVICES
FIGURE 31 ELECTRONIC FINGERTIP
FIGURE 32 COMPONENTS OF BIOSTAMP
FIGURE 33 MYO ARMBAND BY THALMIC LABS
FIGURE 34 NON-CLINICAL BENEFITS
FIGURE 35 WEARABLE MEDICAL DEVICES
FIGURE 36 FITNESS TRACKING DEVICES
FIGURE 37 TYPES OF MHEALTH SERVICES
FIGURE 38 TYPES OF APPS
FIGURE 39 BENEFITS OF BIG DATA
FIGURE 40 BENEFITS OF NETWORK and SERVICES
FIGURE 41 ROLES OF MOBILE OPERATORS
FIGURE 42 ROLE OF HEALTHCARE PROVIDERS
FIGURE 43 MHEALTH: MARKET BY THERAPEUTICS
FIGURE 44 BENEFITS OF MHEALTH IN CVDS
FIGURE 45 BENEFITS OF MHEALTH
FIGURE 46 BENEFITS OF MHEALTH
FIGURE 47 BENEFITS OF MHEALTH
FIGURE 48 BENEFITS OF MHEALTH
FIGURE 49 TYPES OF MHEALTH APPLICATION
FIGURE 50 ADVANTAGES OF REMOTE MONITORING
FIGURE 51 DIAGNOSIS AND TREATMENT SERVICES
FIGURE 52 EDUCATION and AWARENESS SERVICES
FIGURE 53 MHEALTH HEALTHCARE MANAGEMENT
FIGURE 54 GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY
FIGURE 55 APAC: MARKET DRIVERS
FIGURE 56 MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2015)
FIGURE 57 MHEALTH: MERGERS and ACQUISITIONS(2015)
FIGURE 58 MHEALTH: KEY PRODUCT LAUNCH and DEVELOPMENTS (2015)
FIGURE 59 MHEALTH: KEY BUSINESS EXPANSIONS and CONTRACTS (2015)
FIGURE 60 MHEALTH: KEY PATENTS/APPROVALS( 2015)
FIGURE 61 APPLE INC. OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 62 APPLE INC.: NET REVENUE, BY SEGMENT, 2012-2014
FIGURE 63 APPLE INC.: NET REVENUE, BY REGION, 2012-2014
FIGURE 64 ATHENAHEALTH: OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 65 ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION)
FIGURE 66 ATandT INC.: OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 67 ATandT INC.: NET REVENUE BY SEGMENT, 2012-2014
FIGURE 68 BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 69 BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014
FIGURE 70 GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2012-2014
FIGURE 71 GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014
FIGURE 72 GE HEALTHCARE SEGMENT, 2014
FIGURE 73 GOOGLE: OVERALL FINANCIALS, 2012 - 2014 ($BILLION)
FIGURE 74 JandJ: OVERALL FINANCIALS, 2012 - 2014 ($ BILLION)
FIGURE 75 LABCORP OVERALL FINANCIALS ($MILLION), 2012-2014
FIGURE 76 NET REVENUE BY SEGMENTS, 2012-2014
FIGURE 77 NIKE: OVERALL FINANCIALS 2012 - 2014 ($BILLION)
FIGURE 78 NIKE: REVENUE BY REGION (2012-2013)
FIGURE 79 PFIZER: OVERALL FINANCIALS, 2012-2014 ($BILLION)
FIGURE 80 PFIZER: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION)
FIGURE 81 PFIZER: FINANCIALS BY REGION, 2012-2013 ($BILLION)
FIGURE 82 PHILIPS: OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 83 PHILIPS: FINANCIALS BY REGION, 2012-2014 ($MILLION)
FIGURE 84 PHILIPS: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION)
FIGURE 85 QUALCOMM INC.: OVERALL FINANCIALS, 2012-2014 ($BILLION)
FIGURE 86 QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION)
FIGURE 87 QUALCOMM INC.: NET REVENUE, BY REGION, 2012-2014 ($MILLION)
FIGURE 88 QUEST: OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 89 QUEST: NET REVENUE BY SEGMENTS, 2013-2014 ($MILLION)
FIGURE 90 ROCHE: OVERALL FINANCIALS, 2012-2014 ($BILLION)
FIGURE 91 ROCHE: NET REVENUE, BY SEGMENTS, 2012-2014 ($BILLION)
FIGURE 92 SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 93 SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 94 SANOFI PHARMA: NET REVENUE BY SEGMENT, 2012-2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.